Kaiser Health News
Country has grown increasingly dependent on the health sector to power the economy as Obamacare helped boost job growth, experts say.
Patent laws, government incentives, meant to encourage development of less-profitable drugs, enable some companies to get a leg up, set high prices.
Congressional records show those eight, including Celgene and Mylan, kicked in an extra $4.42 million versus that quarter last year.
News of Marathon's resignation comes after wide criticism for $89,000 price tag for Emflaza, a drug for Duchenne muscular dystrophy drug.
Employers in New York, Michigan and Illinois accounted for the most H-1B visa applications for foreign physicians, nearly a third of the total.
The compromise could be letting states decide whether to seek a federal waiver to change the essential health benefits.
Health companies spent more than $2 million to buy access to incoming administration via candlelight dinners, balls, other events, filings show.
PhRMA Senior VP Scott LaGanga led Partnership for Safe Medicines, which recently emerged as leading voice against bills allow drug imports.
Grassley has asked CMS officials to explain why they failed to collect nearly $125 million in potential overcharges.
Under federal law, state Medicaid programs must cover "early and periodic screening, diagnostic, and treatment services" for children under age 21.